Blood-brain Barrier Damage is Pivotal for SARS-CoV-2 Infection to the Central Nervous System
Jahir Rodríguez-Morales, Sebastián Guartazaca-Guerrero, Salma A. Rizo-Téllez, Rebeca Viurcos-Sanabria, Eira Valeria Barrón-Palma, Aldo Francisco Hernández Valencia, Porfirio Nava, Galileo Escobedo, José Damián Carrillo-Ruiz, Lucía Angélica Méndez-García · Experimental Neurobiology · 2022
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Experimental Neurobiology · OpenAlex · article · 2022
Abstract
Transsynaptic transport is the most accepted proposal to explain the SARS-CoV-2 infection of the CNS. Nevertheless, emerging evidence shows that neurons do not express the SARS-CoV-2 receptor ACE2, which highlights the importance of the blood-brain barrier (BBB) in preventing virus entry to the brain. In this study, we examine the presence of SARS-CoV-2 messenger ribonucleic acid (mRNA) and the cytokine profile in cerebrospinal fluids (CSF) from two patients with a brain tumor and COVID-19. To determine the BBB damage, we evaluate the Q- albumin index, which is an indirect parameter to assess the permeability of this structure.
The Q-albumin index of the patient with an intraventricular brain tumor suggests that the BBB is undamaged, preventing the passage of SARS-CoV-2 and pro-inflammatory molecules. The development of brain tumors that disrupt the BBB (measured by the Q-albumin index), in this case, a petroclival meningioma (Case 1), allows the free passage of the SARS-CoV-2 virus and probably lets the free transit of pro-inflammatory molecules to the CNS, which leads to a possible activation of the microglia (astrogliosis) and an exacerbated immune response represented by IL-13, IFN-γ, and IL-2 trying to inhibit both the infection and the carcinogenic process.
Open the resolved locator · 10.5607/en21049
Metadata licence: OpenAlex metadata (CC0)